CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 64918-65213 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/cb16d307afaecebd683e6d74c8b501ed54b0c9a4","sourcedb":"CORD-19","sourceid":"cb16d307afaecebd683e6d74c8b501ed54b0c9a4","text":"Based on the existing TGFbR1 inhibitors, Guckian and colleagues [140] described a series of TGFbR1 kinase inhibitors including a pyrazolone group which allowed replacement of the ubiquitous nitrogen H-bond acceptor within the core with a carbonyl without remarkable loss in biochemical activity.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T372","span":{"begin":0,"end":295},"obj":"Sentence"},{"id":"T65696","span":{"begin":0,"end":295},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T372","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T65696","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T86","span":{"begin":0,"end":295},"obj":"Sentence"}],"attributes":[{"subj":"T86","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#c593ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93ecab"}]}]}}